Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report ...

Multiple executives at Tempus AI Inc. executed significant share sales totaling $20.3 million between Feb. 4-7, according to ...

Sabre (NASDAQ:SABR – Get Free Report) and Tempus AI (NASDAQ:TEM – Get Free Report) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses ...

Cathie Wood's comeback could continue through the year as most of her Ark Invest funds come roaring back alongside the tech ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

In a regulatory filing, Tempus AI (TEM) disclosed that COO Ryan Fukushima sold 20,000 shares of the company’s stock. The ...

Gottlieb, who led the agency during the first Trump presidency, supports a reversion to an earlier interpretation of the 21st Century Cures Act.

Let's explore the Tempus AI stock price and whether it is a good company to buy and hold despite its overvaluation.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, recently announced it has completed its acquisition of Ambry Genetics, a ...

TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI (TEM) with a Buy rating and price target of $74, up from $58, following the ...

This page features the latest news about the Tempus AI stock. Tempus AI shares get Overweight rating from Morgan Stanley On Tuesday, Tempus AI Inc (NASDAQ:TEM) received an Overweight rating from ...